DK48382A - Fremgangsmaade til fremstilling af en pharmaceutisk parenteraldosisenhed indeholdende et lyophiliseret penicillinderivat - Google Patents

Fremgangsmaade til fremstilling af en pharmaceutisk parenteraldosisenhed indeholdende et lyophiliseret penicillinderivat

Info

Publication number
DK48382A
DK48382A DK48382A DK48382A DK48382A DK 48382 A DK48382 A DK 48382A DK 48382 A DK48382 A DK 48382A DK 48382 A DK48382 A DK 48382A DK 48382 A DK48382 A DK 48382A
Authority
DK
Denmark
Prior art keywords
pharmaceutical
preparing
procedure
dosage unit
unit containing
Prior art date
Application number
DK48382A
Other languages
English (en)
Other versions
DK157976C (da
DK157976B (da
Inventor
B E Haeger
Original Assignee
American Cyanamid Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22935482&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK48382(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by American Cyanamid Co filed Critical American Cyanamid Co
Publication of DK48382A publication Critical patent/DK48382A/da
Publication of DK157976B publication Critical patent/DK157976B/da
Application granted granted Critical
Publication of DK157976C publication Critical patent/DK157976C/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425Thiazoles
    • A61K31/429Thiazoles condensed with heterocyclic ring systems
    • A61K31/43Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK048382A 1981-03-26 1982-02-04 Fremgangsmaade til fremstilling af en farmaceutisk, parenteral, til hurtig rekonstitution egnet dosisenhed af lyofiliseret natriumsalt af 6-(2-(4-ethyl-2,3-dioxo-1-piperazincarboxamido)-2-phenylacetamid)-3-3-dimethyl-7-oxo-4-thia-1-azabicyclo(3,2,0)heptan-2-carboxylsyre DK157976C (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US24758681A 1981-03-26 1981-03-26
US24758681 1981-03-26

Publications (3)

Publication Number Publication Date
DK48382A true DK48382A (da) 1982-09-27
DK157976B DK157976B (da) 1990-03-12
DK157976C DK157976C (da) 1990-08-27

Family

ID=22935482

Family Applications (1)

Application Number Title Priority Date Filing Date
DK048382A DK157976C (da) 1981-03-26 1982-02-04 Fremgangsmaade til fremstilling af en farmaceutisk, parenteral, til hurtig rekonstitution egnet dosisenhed af lyofiliseret natriumsalt af 6-(2-(4-ethyl-2,3-dioxo-1-piperazincarboxamido)-2-phenylacetamid)-3-3-dimethyl-7-oxo-4-thia-1-azabicyclo(3,2,0)heptan-2-carboxylsyre

Country Status (23)

Country Link
JP (1) JPS57159708A (da)
AT (1) AT395533B (da)
AU (1) AU549784B2 (da)
BE (1) BE892541A (da)
CA (1) CA1209477A (da)
CH (1) CH652306A5 (da)
DE (2) DE3208505A1 (da)
DK (1) DK157976C (da)
ES (1) ES509234A0 (da)
FR (1) FR2502624B1 (da)
GB (1) GB2095551B (da)
GR (1) GR78386B (da)
HK (1) HK39189A (da)
HU (1) HU186489B (da)
IE (1) IE52936B1 (da)
IL (1) IL64924A (da)
IT (1) IT1147916B (da)
LU (1) LU84031A1 (da)
NL (1) NL192664C (da)
NZ (1) NZ199632A (da)
PL (1) PL130564B1 (da)
SE (1) SE453153B (da)
ZA (1) ZA82605B (da)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6207661B1 (en) * 1999-02-22 2001-03-27 Baxter International Inc. Premixed formulation of piperacillin sodium and tazobactam sodium injection
KR100931784B1 (ko) 2003-10-23 2009-12-14 오츠카 세이야쿠 가부시키가이샤 방출조절성 멸균 아리피프라졸 주사제, 그 제조방법
ITMI20051630A1 (it) * 2005-09-02 2007-03-03 Acs Dobfar Spa Formulazione farmaceutica sterile iniettabile contenente almeno due principi attivi
LT2170279T (lt) 2007-07-31 2018-03-12 Otsuka Pharmaceutical Co., Ltd. Aripiprazolo suspensijos ir liofilizuotos kompozicijos gamybos būdai
CN114200057A (zh) * 2021-12-14 2022-03-18 坛墨质检科技股份有限公司 一种可替代标准溶液的抗生素类药物固体混合标准物质的制备方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2608507A (en) * 1949-08-20 1952-08-26 Sharp & Dohme Inc Dialkyl sulfamyl benzoic acids
CH546783A (de) * 1971-03-11 1974-03-15 Hoffmann La Roche Verfahren zur herstellung von penicilloinsaeurederivate.
JPS5817728B2 (ja) * 1973-11-20 1983-04-09 山之内製薬株式会社 アンピシリンナトリウムエン ノ セイホウ
IL47168A (en) * 1974-05-09 1979-07-25 Toyama Chemical Co Ltd Mono or dioxo piperazino(thio)carbonylamino derivatives ofpenicillins and cephalosporins and process for producing the same
JPS52143221A (en) * 1976-05-22 1977-11-29 Yamanouchi Pharmaceut Co Ltd Novel preparations for rectal administration
DE2623835C2 (de) * 1976-05-28 1978-03-02 C.H. Boehringer Sohn, 6507 Ingelheim Verfahren zur Herstellung von Natriumampicillin
JPS542337A (en) * 1977-06-08 1979-01-09 Toyama Chem Co Ltd Bactericidal composition for medical use
FR2403078A1 (fr) * 1977-09-19 1979-04-13 Lafon Labor Nouveau procede de preparation de formes pharmaceutiques, cosmetiques ou de diagnostic
JPS54147917A (en) * 1978-05-08 1979-11-19 Sumitomo Chem Co Ltd Ferrze-drying method
PT70225A (en) * 1978-10-03 1979-10-01 Gist Brocades Nv Process for the preparation of sodium amoxicillin preparations
DE2925009A1 (de) * 1979-06-21 1981-01-08 Basf Ag Zubereitung fuer substanzen, verfahren zu deren herstellung und deren verwendung

Also Published As

Publication number Publication date
ES8302455A1 (es) 1982-12-16
IE52936B1 (en) 1988-04-13
SE8200591L (sv) 1982-09-27
ATA92982A (de) 1992-06-15
LU84031A1 (de) 1982-07-08
AU7986582A (en) 1982-09-30
DK157976C (da) 1990-08-27
ZA82605B (en) 1982-12-29
DK157976B (da) 1990-03-12
IL64924A0 (en) 1982-04-30
CH652306A5 (de) 1985-11-15
GR78386B (da) 1984-09-26
HU186489B (en) 1985-08-28
CA1209477A (en) 1986-08-12
FR2502624A1 (fr) 1982-10-01
BE892541A (fr) 1982-09-20
NL192664B (nl) 1997-08-01
IL64924A (en) 1985-07-31
NL8201251A (nl) 1982-10-18
DE19375106I2 (de) 2006-02-16
GB2095551B (en) 1984-10-03
ES509234A0 (es) 1982-12-16
NZ199632A (en) 1985-07-12
IT1147916B (it) 1986-11-26
AT395533B (de) 1993-01-25
PL235509A1 (da) 1982-12-20
HK39189A (en) 1989-05-19
SE453153B (sv) 1988-01-18
FR2502624B1 (fr) 1985-10-25
IT8248034A0 (it) 1982-03-19
DE3208505A1 (de) 1982-10-21
JPH0219804B2 (da) 1990-05-07
AU549784B2 (en) 1986-02-13
IE820703L (en) 1982-09-26
GB2095551A (en) 1982-10-06
DE3208505C2 (da) 1991-11-28
NL192664C (nl) 1997-12-02
PL130564B1 (en) 1984-08-31
JPS57159708A (en) 1982-10-01

Similar Documents

Publication Publication Date Title
DK158873C (da) Fremgangsmaade til stabilisering af et lyofiliseret farmaceutisk interferonpraeparat
NO177038C (no) Fremgangsmåte for fremstilling av et farmasöytisk doseringssystem
DK162877C (da) Depotplaster til indgift af et laegemiddel
FI831740A0 (fi) Foerfarande foer framstaellning av ett seskviterpenlaktonhaltigt farmaceutiskt extrakt
DK365883A (da) Fremgangsmaade til fremstilling af en langtidsvirkende farmaceutisk tablet
NO168745C (no) Fremgangsmaate for fremstilling av farmasoeytisk blandingspreparat
DK645788A (da) Anvendelse af ergolinderivater til fremstilling af et farmaceutisk praeparat
DK280282A (da) Fremgangsmaade til fremstilling af farmaceutiske praeparater indeholdende ergotalkaloider
DK203879A (da) Fremgangsmaade til fremstilling af en farmaceutisk doseringskomponent
DK220983D0 (da) Fremgangsmade til fremstilling af et cyclisk peptidderivat benaevnt a-21978c
DK22879A (da) Fremgangsmaade til fremstilling af et medikamentafgivelsessystem
NO824112L (no) Fremgangsmaate for fremstilling av et fluorbiprofenderivat
DK689188D0 (da) Anvendelse af piperidin-derivater til fremstilling af et farmaceutisk praeparat
DK48382A (da) Fremgangsmaade til fremstilling af en pharmaceutisk parenteraldosisenhed indeholdende et lyophiliseret penicillinderivat
DK352578A (da) Fremgangsmaade til fremstilling af et farmaceutisk praeparat
DK473088D0 (da) Anvendelse af 2-amino-6-trifluormethoxybenzothiazol til fremstilling af et laegemiddel
DK221283D0 (da) Fremgangsmade til fremstilling af et cyclisk peptidderivat benaevnt a-21978c
DK206582A (da) Fremgangsmaade til fremstilling af et furanderivat
DK471181A (da) Fremgangsmaade til fremstilling af et pyrimidinderivat
DK345681A (da) Fremgangsmaade til femstilling af et farmaceutisk praeparat
DK651588A (da) Anvendelse af en forbindelse til fremstilling af et farmaceutisk praeparat til behandling af fibromyalgia
DK249083D0 (da) Fremgangsmade til fremstilling af et pharmaceutisk praeparat til indgivelse af anti-androgent aktive forbindelser
DK157183A (da) Fremgangsmaade til fremstilling af et insulinderivat
DK155682A (da) Fremgangsmaade til fremstilling af et psykotropt laegemiddel
DK212678A (da) Fremgangsmaade til fremstilling af et farmaceutisk praeparat indeholdende en nitroimidazol